Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cardiome Pharma Corp
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cardiome Pharma Corp since year 2005.
Table 2 shows the detailed insider transactions of Cardiome Pharma Corp since 2005.
The reporting company's ticker symbol is CRME. The reporting company's CIK number is 1036141.
The total value of stock buying since 2005 is $3,919,000.
The total value of stock sales since 2005 is $9,028,000.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2010-04-14||Gross Phillip (10% Owner)||Sale||650,000||7.92||5,148,000|
|2010-04-05||Gross Phillip (10% Owner)||Sale||500,000||7.76||3,880,000|
|2009-04-09||Gross Phillip (10% Owner)||Buy||1,000,000||3.92||3,919,000|
Insider trading activities including stock purchases, stock sales, and option exercises of CRME listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cardiome Pharma Corp (symbol CRME, CIK number 1036141) see the Securities and Exchange Commission (SEC) website.